Endometrial hyperplasia in peri- and postmenopausal women

Close metadata

Recommended articles:

Prognosis and prevention of recurrent and atypical endometrial hyperplasia in women of reproductive age. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):59-65

Experience of using a drug containing polypeptides of the bladder of cattle in the treatment of patients with overactive bladder in perimenopause. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):91-99

Comparative analysis of the effectiveness of therapy for endometrial hyperplasia in women of reproductive age. Russian Bulletin of Obstetrician-Gynecologist. 2025;(2):75-83

Compression elastography as a new method of ultrasound imaging in the differential diagnosis of chronic tonsillitis. Russian Bulletin of Otorhinolaryngology. 2024;(4):20-25

Ultrasonography for peritonsillar abscess diagnosis: benefits and drawbacks. Russian Bulletin of Otorhinolaryngology. 2024;(4):81-85

Non-invasive automated methods for the diagnosis of periorbital skin tumors. Russian Annals of Ophthalmology. 2024;(5):137-145

Endometrial adenocarcinoma with mutations in POLE, TP53 genes and microsatellite instability. Russian Journal of Archive of Pathology. 2024;(6):58-62

Clinical and anamnestic features of rosacea in women in perimenopausal period. Russian Journal of Clinical Dermatology and Venereology. 2025;(1):49-55

Live birth rates after conservative treatment of atypical hyperplasia and initial endometrial cancer. Russian Journal of Human Reproduction. 2025;(1):78-85

Clinical and Ultrasound Semiotics of Varicose Vein Recurrence. Journal of Venous Disorders. 2025;(1):28-36

The great clinical significance of hyperplastic processes in the endometrium is that they are one of the most common causes of uterine bleeding in women aged 45—55 years and their hospitalization in hospital. Endometrial hyperplasia, especially with atypia, is a significant clinical problem because it can precede endometrial cancer. Over the past few years, the assessment of the condition of the endometrium has changed in the recognition that the pathology of the endometrium is not always global in nature. Endometrial thickness is not may be the only sign of endometrial hyperplasia.

Keywords:

endometrial hyperplasia

endometrial polyp

endometrial cancer

perimenopause

postmenopause

endometrial thickness

ultrasound examination

Authors:

Kapitanova O.V.

Moscow Regional Research Institute of Obstetrics and Gynecology, Moscow, Russia

Chechneva M.A.

Moskovskiĭ oblastnoĭ NII akusherstva i ginekologii

List of references:

Makarov IO. Oncological aspects of hyperplastic processes in the endometrium. . 2011;1:13-16. (In Russ.).
Maksimov SYa, Guseinov KD, Kosnikov AG. Risk factors for cancer neoplasms of the female reproductive system. . 2013;53:4:496-501. (In Russ.).
Guide to gynecology. Ed. akad. RAMN, prof. Ailamazyan E.K. M.: MEDpress-inform; 2012. (In Russ.).
Savel’eva GM, Breusenko VG, Kappusheva LM. Postmenopausal. Physiology and pathology. . 2008;2:56-59. (In Russ.).
Ashrafyan LA, Novikova EG. Gynecological aspects in trends morbidity and mortality from cancer of the reproductive system. . 2011;1:XLX:27-33. (In Russ.).
Dobrokhotova YuI, Saprykina LV. M.: GEOTAR-Media; 2018. (In Russ.).
Vikhlyaeva EM. M.: MIA; 2006. (In Russ.).
Strizhakov AN, Davydov AI, Pashkov VM. M. 2011. (In Russ.).
Sidorova IS, Unanyan AD, Vlasov PC, Evkina I, Karpov D. Hyperplastic processes of endometrium: the features of clinic and therapy. . 2011;3:40-42.(In Russ.).
Serov VN. M. 2008. (In Russ.).
Ragupathy, K, Cawley, N, Ridout, A, Iqbal, P, Alloub, M. Nonassessable endometrium in women with post-menopausal bleeding: to investigate or ignore. . 2013;288:375-378.
Manukhin IB, Taktarov VG, Shmeleva SV. A guide. (Seriya «Prakticheskie rukovodstva»). 2010. (In Russ.).
Serov VN, Sukhikh GT, Prilepskaya VN, Radzinskii VE. M.: GEOTAR-Media; 2016. (In Russ.).
Aksel’ EM. Morbidity and mortality from malignant diseases neoplasms of the female reproductive system in Russia. . 2015;1:4-13. (In Russ.).
Endometrial cancer. Practice Bulletin N 149. American College of Obstetricians and Gynecologists. . 2015;125:1006-1026.
Bokhman YaV. M.: OOO Meditsinskoe informatsionnoe agentstvo; 2007. (In Russ.).
Bochkareva NV, Fomina SV, Kolomiets LA. Development of endometrial cancer in patients with different age groups with endometrial hyperplastic processes. . 2009;3:333-338. (In Russ.).
Kuznetsov RE, Chernekhovskaya NE, Andreev VG, Povalyaev AV. M.: MEDpress-inform; 2009. (In Russ.).
Baburin DV, Unanyan AL. Management tactics for patients with atypical endometrial hyperplasia. . 2016;4:188-192. (In Russ.).
Epidemiology and investigations for suspected endometrial cancer. Joint SOGC-GOC-SCC Clinical Practice Guideline. . 2013;291:1-9.
Timmermans A, Opmeer BC, Khan KS, Bachmann LM, Epstein E, Clark TJ, Gupta JK, Bakour SH, van den Bosch T, van Doorn HC, Cameron ST, Giusa MG, Dessole S, Dijkhuizen FP, Ter Riet G, Mol BW. Endometrial thickness measurement for detecting endometrial cancer in women with postmenopausal bleeding: a systematic review and metaanalysis. . 2010;116:160-167.
Colombo N, Preti E, Landoni F, Carinelli S, Colombo A, Marini C, Sessa C; ESMO Guidelines Working Group. Endometrial cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. 2013;24:6:33-38.
Giannella L, Cerami LB, Setti T, Bergamini E, Boselli F. Prediction of Endometrial Hyperplasia and Cancer among Premenopausal Women with Abnormal Uterine Bleeding. . 2019;2019:8598152.
Trimble CL, Method M, Leitao M, Lu K, Ioffe O, Hampton M, Higgins R, Zaino R, Mutter GL. Society of Gynecologic Oncology Clinical Practice Committee. Management of endometrial precancers. . 2012;120:1160-1175.
A guide for doctors. Ed. Trufanova G.E., Panova V.O. SPb.: ELBI-SPb; 2008. (In Russ.).
Benaserraf B, Goldstein S, Grotsman I. M.: MEDpress-inform; 2016. (In Russ.).
Borovkova LV, Ershova VO, Ignat’ev AA. Modern diagnostic methods benign and malignant endometrial processes. . 2009;3:105-108. (In Russ.).
Bulanov MN. M.: Vidar-M; 2010. (In Russ.).
Sukhikh GT, Smetnik VP, Andreeva EN, Balan VE, Gavisova AA, Grigoryan OR, Ermakova EI, Zaidieva YaZ, Il’ina LM, Kasyan VN, Marchenko LA, Podzolkova NM, Rogovskaya SI, Smetnik AA, Chernukha GE, Yureneva SV. KR117 30 Menopausal hormone therapy and preservation of women’s health in adulthood. Clinical recommendations. . 2016;8-9. (In Russ.).
Baber RJ, Panay N, Fenton A, and the IMS Writing Group. 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy. 2016;19:2:109-150.
Demicheva TV, Grishin GN, Krikunova LI. The role of ultrasound in the diagnosis of endometrial cancer and assessment of the stage of the disease. . 2012;4:28-31. (In Russ.).
Jokubkiene L, Sladkevicius P, Valentin L. Transvaginal ultrasound examination of the endometrium in postmenopausal women without vaginal bleeding. . 2016;48:3:390-396. PMID:26678251.
Sabantsev MA, Bazhenova LG, Shramko SV, Levchenko VG, Markina LA, Khvostova EP. The informative value of conventional methods of diagnosis of proliferative diseases of the endometrium. 2017;17:1:62-66. (In Russ.).
Breijer MC, Peeters JA, Opmeer BC, Clark TJ, Verheijen RH, Mol BW, Timmermans A. Capacity of endometrial thickness measurement to diagnose endometrial carcinoma in asymptomatic postmenopausal women: a systematic review and metaanalysis. . 2012;40:621-629.
Ozerskaya IA. M.: Vidar-M; 2013. (In Russ.).
Lev-Sagie A, Hamani Y, Imbar T, Hurwitz A, Lavy Y. The significance of intrauterine lesions detected by ultrasound in asymptomatical postmenopausal women. . 2005;112:379-382.
Ozelci R, Dilbaz B, Akpınar F, Kınay T, Baser E, Aldemir O, Altınbas SK. The significance of sonographically thickened endometrium in asymptomatic postmenopausal women. . 2019;62:4:273-279.
Li Z, Li L. Risk of malignancies among asymptomatic postmenopausal women with thickened endometrium: A cohort study. . 2019;98:6:e14464.
Alcázar JL, Bonilla L, Marucco J, Padilla AI, Chacón E, Manzour N, Salas A. Risk of endometrial cancer and endometrial hyperplasia with atypia in asymptomatic postmenopausal women with endometrial thickness ≥11 mm: A systematic review and meta-analysis. . 2018;46:9:565-570.
Ghoubara A, Emovon E, Sundar S, Ewies A. Thickened endometrium in asymptomatic postmenopausal women — determining an optimum threshold for prediction of atypical hyperplasia and cancer. . 2018;38:8:1146-1149.
Louie M, Canavan TP, Mansuria S. Threshold for endometrial sampling among postmenopausal patients without vaginal bleeding. . 2016;132:3:314-317.
Wolfman W, Leyland N, Heywood M, Singh SS, Rittenberg DA, Soucy R, Allaire C, Awadalla A, Best C, Dunn S, Leroux N, Potestio F, Senikas V, Wallace S, Menzies R; Society of Obstetricians and Gynaecologists of Canada. Asymptomatic endometrial thickening. . 2009;32:10:990-999.
Genc M, Genc B, Sahin N, Celik E, Turan GA, Gur EB, Guclu S. Endometrial pathology in postmenopausal women with no bleeding. 2015;18:2:241-245.
Adamyan LV, Mel’nikova NS, Kasyan VN. The endometrial pathology in postmenopausal women: do we need ultrasound screening? . 2019;25:2:113-119. (In Russ.).
Litta P, Di Giuseppe J, Moriconi L, Delli Carpini G, Piermartiri MG, Ciavattini, A. Predictors of malignancy in endometrial polyps: a multi-institutional cohort study. 2014;35:4:382-386.
Ricciardi E, Vecchione A, Marci R, Schimberni M, Frega A, Maniglio P, Caserta D, Moscarini M. Clinical factors and malignancy in endometrial polyps. Analysis of 1027 cases. . 2014;183:121-124.
Gambadauro P, Martinez-Maestre MA, Schneider J, Torrejon R. Endometrial polyp or neoplasia? A case-control study in women with polyps at ultrasound. 2015;18:3:399-404.
Ferrazzi E, Zupi E, Leone FP, Savelli L, Omodei U, Moscarini M, Barbieri M, Cammareri G, Capobianco G, Cicinelli E, Coccia ME, Donarini G, Fiore S, Litta P, Sideri M, Solima E, Spazzini D, Testa AC, Vignali M. How often endometrial polyps malignant in asymptomatic postmenopausal women? A multicenter study. 2009;200:3:235.

Close metadata